The Acute and Chronic Effects of Sulfonylurea Therapy in Type II Diabetic Subjects

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Diabetes

• Publication date

  1984-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/diab.33.4.346PMID 6423429
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Potentiation of Insulin Action by a Sulfonylurea in Primary Cultures of Hepatocytes from Normal and Diabetic Rats

  1983cited by this paper
• Sulphonylureas and insulin receptors: Effects in vivo and in vitro

  1982cited by this paper
• The Effect of Chronic Sulfonylurea Therapy on Hepatic Glucose Production in Non-insulin-dependent Diabetes

  1982cited by this paper
• Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus.

  1981cited by this paper
• Selective potentiation of insulin-mediated glucose disposal in normal dogs by the sulfonylurea glipizide.

  1981cited by this paper
• In vitro effects of a sulfonylurea on insulin action in adipocytes. Potentiation of insulin-stimulated hexose transport.

  1981cited by this paper
• Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects.

  1980cited by this paper
• Classification and Diagnosis of Diabetes Mellitus and Other Categories of Glucose Intolerance

  1979cited by this paper
• Glucose clamp technique: a method for quantifying insulin secretion and resistance.

  1979cited by this paper
• Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes.

  1979cited by this paper
• Increased insulin sensitivity and cellular insulin binding in obese diabetics following treatment with glibenclamide.

  1979cited by this paper
• SULFONYLUREAS INCREASE THE NUMBER OF INSULIN RECEPTORS

  1979cited by this paper
• Influence of hyperinsulinemia, hyperglycemia, and the route of glucose administration on splanchnic glucose exchange.

  1978cited by this paper
• Sulphonylureas increase the number of insulin receptors

  1978cited by this paper
• The role of insulin resistance in the pathogenesis of diabetes mellitus.

  1978cited by this paper
• Plasma insulin and glucose levels in maturity onset diabetics treated with chlorpropamide

  1977cited by this paper
• Integrated control of hepatic glucose metabolism.

  1977cited by this paper
• Glucose homeostasis during prolonged suppression of glucagon and insulin secretion by somatostatin.

  1977cited by this paper
• Gluconeogenesis: methodological approaches in vivo.

  1977cited by this paper
• The Effect of Chronic Oral Antidiabetic Therapy on Insulin and Glucagon Responses to a Meal

  1977cited by this paper
• Decreased insulin binding to adipocytes and circulating monocytes from obese subjects.

  1976cited by this paper
• The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes

  1976cited by this paper
• Effects of sulfonylurea therapy on insulin binding to mononuclear leukocytes of diabetic patients.

  1976cited by this paper
• Nonketotic diabetes mellitus: insulin deficiency or insulin resistance?

  1976cited by this paper
• Insulin control of glucose metabolism in man: a new kinetic analysis.

  1975cited by this paper
• A model of the kinetics of insulin in man.

  1974cited by this paper
• Effect of short and long term chlorpropamide treatment of insulin release and blood-glucose.

  1974cited by this paper
• Insulin Binding to Isolated Human Adipocytes

  1974cited by this paper
• Diurnal variations of serum insulin, total glucagon, cortisol, glucose and free fatty acids in normal and diabetic subjects before and after treatment with chlorpropamide.

  1974cited by this paper
• Glucose turnover and disposal in maturity-onset diabetes.

  1973cited by this paper
• Effect of chronic sulfonylurea therapy on plasma insulin and proinsulin levels.

  1972cited by this paper
• Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays.

  1971cited by this paper
• Effect of Chlorpropamide on Serum Glucose and Immunoreactive Insulin Concentrations in Patients with Maturity-onset Diabetes Mellitus

  1967cited by this paper
• Quantitative effects of glucose, sulfonylureas, salicylate, and indole-3-acetic acid on the secretion of insulin activity into pancreatic venous blood.

  1962cited by this paper
• Comparison of Plasma Insulin Levels Following Administration of Tolbutamide and Glucose

  1960cited by this paper
• INFLUENCES OF GLUCOSE LOADING AND OF INJECTED INSULIN ON HEPATIC GLUCOSE OUTPUT *

  1959cited by this paper
• CLINICAL AND EXPERIMENTAL STUDIES OF INSULIN SECRETION FOLLOWING TOLBUTAMIDE AND METAHEXAMIDE ADMINISTRATION

  1959cited by this paper
• Plasma Glucose Turnover in Humans as Studied with C14 Glucose : Influence of Insulin and Tolbutamide

  1959cited by this paper

• Synthesis, molecular docking study, molecular dynamics simulation and ADMET prediction of new Sulfa drugs having CA II Inhibitory effect and antidiabetic activity.

  2025cites this paper
• Tirzépatide, sensibilité et sécrétion d’insuline

  2023cites this paper
• Antihyperglycemic and antidyslipidemic effects of Artemisia arborescens aqueous extract in streptozotocin-induced diabetic rat.

  2022cites this paper
• Antihyperglycemic effect of aqueous extract of Tetraclinis articulata in streptozotocin-induced diabetic rats and acute toxicity analysis.

  2022cites this paper
• Shift of Glucose Peak Time During Oral Glucose Tolerance Test is Associated with Changes in Insulin Secretion and Insulin Sensitivity After Therapy with Antidiabetic Drugs in Patients with Type 2 Diabetes

  2021cites this paper
• Diabetes Mellitus

  2021cites this paper
• Effect of Terebinthus atlanticus on Glucose Metabolism in Diabetic Rats

  2020cites this paper
• In-vitro and in-vivo performance of locally manufactured glimepiride tablet generics compared to the innovator (Amaryl®) tablets

  2020cites this paper
• Investigation of the synergistic effect of glimepiride and rosuvastatin on alloxan-induced diabetic rat

  2020cites this paper
• Evaluation of glucose and lipid lowering activity of Arganimide A in normal and streptozotocin-induced diabetic rats.

  2018cites this paper
• Glycemic control of type 2 diabetes mellitus across stages of renal impairment: information for primary care providers

  2018cites this paper
• Impact of insulin sensitivity, beta‐cell function and glycaemic control on initiation of second‐line glucose‐lowering treatment in newly diagnosed type 2 diabetes

  2017cites this paper
• Comparative Study between Oral Hypoglycemic Drugs Repaglinide, Glibenclamide and Rosiglitazone on Some Biochemical Parameters in Type 2 Diabetic Patients

  2017cites this paper
• Cardiovascular Disease and Diabetes: Two Sides of the Same Coin!

  2017cites this paper
• Potent antihyperglycemic and hypoglycemic effect of Tamarix articulata Vahl. in normal and streptozotocin-induced diabetic rats.

  2017cites this paper
• Mechanistic Insight and Management of Diabetic Nephropathy: Recent Progress and Future Perspective

  2017cites this paper
• Skeletal Muscle TRIB3 Mediates Glucose Toxicity in Diabetes and High- Fat Diet–Induced Insulin Resistance

  2016cites this paper
• Simultaneous Determination of Bosentan, Glimepiride, HYBOS and M1 in Rat Plasma by UPLC-MS-MS and its Application to Pharmacokinetic Study.

  2016cites this paper
• New oral diabetes drugs are more effective than older Agents: real or a fraud?

  2016cites this paper
• Short-Term High-Fat Diet (HFD) Induced Anxiety-Like Behaviors and Cognitive Impairment Are Improved with Treatment by Glyburide

  2016cites this paper
• Chapter 40 – Type 2 Diabetes Mellitus: Etiology, Pathogenesis, and Natural History

  2016cites this paper
• Pancreatic regulation of glucose homeostasis

  2016cites this paper
• Sulfonylurea Glimepiride: A Proven Cost Effective, Safe and Reliable War Horse in Combating Hyperglycemia in Type 2 Diabetes

  2015cites this paper
• Pathomorphological and Biochemical Studies on the Effect of Gymnema Sylvestre and Chromium in Induced Diabetes in Rats

  2015cites this paper
• Sulfonylureas and meglitinides: insights into physiology and translational clinical utility

  2015cites this paper
• To Compare the Effect of Oral Hypoglycaemic Drugs Glibenclamide and Pioglitazone on Blood Sugar, Lipid Abnormalities in Type 2 Diabetes Mellitus.

  2014cites this paper
• Post-meal β-cell function predicts the efficacy of glycemic control in patients with type 2 diabetes inadequately controlled by metformin monotherapy after addition of glibenclamide or acarbose

  2014cites this paper
• Pathomorphological Studies on Induced Diabetes in Rats and Evaluation of Antidiabetic Efficacy of Pterocarpus Marsupium and Swertia Chirayita Extrac

  2013cites this paper
• TRIB3 Mediates Glucose-Induced Insulin Resistance via a Mechanism That Requires the Hexosamine Biosynthetic Pathway

  2013cites this paper
• Decreasing Postprandial Plasma Glucose Using an α-Glucosidase Inhibitor in Subjects with IGT for the Prevention of Type 2 Diabetes Mellitus: The STOP-NIDDM Trial

  2012cites this paper
• Insulin should be prescribed at the outset of diagnosis of type 2 diabetes

  2011cites this paper
• Pathogenesis of type 2 diabetes

  2011cites this paper
• Treatment of diabetic vasculopathy: an overview

  2011cites this paper
• Selective, sensitive, and rapid liquid chromatography – tandem mass spectrometry method for determination of Glimepiride in human plasma

  2010cites this paper
• TYPE 2 DIABETES MELLITUS: Etiology, Pathogenesis, and Natural History

  2010cites this paper
• Comparison of insulin sensitivity, glucose sensitivity, and first phase insulin secretion in patients treated with repaglinide or gliclazide

  2010cites this paper
• Early Insulin Use in Type 2 Diabetes

  2009cites this paper
• 2-Deoxyglucose tissue levels and insulin levels following tolazamide dosing in normal and obese mice.

  2009cites this paper
• Mechanism of Metf ormin Action in Obese and Lean Noninsulin-Dependent Diabetic Subjects*

  2008cites this paper
• Nano-sized copper as an efficient catalyst for one pot three component synthesis of thiazolidine-2,4-dione derivatives

  2008cites this paper
• Type 2 diabetes and oral antihyperglycemic drugs.

  2008cites this paper
• Efficacy of glimepiride in Japanese type 2 diabetic subjects.

  2005cites this paper
• Improved liquid chromatographic tandem mass spectrometric determination and pharmacokinetic study of glimepiride in human plasma.

  2005cites this paper
• Hypoglycaemic and anti-hyperglycaemic drugs for the control of diabetes

  2005cites this paper
• Bioequivalence evaluation of two brands of glimepiride 4 mg tablets in healthy subjects.

  2005cites this paper
• Effects of a combination of bedtime intermediate-acting insulin and glibenclamide in type 2 (non-insulin-dependent) diabetic patients with secondary failure to respond to oral hypoglycaemic agents

  2004cites this paper
• Effects of glimepiride on insulin secretion and sensitivity in patients with recently diagnosed type 2 diabetes mellitus.

  2004cites this paper
• Phosphatidylinositol 3-kinase activation is required for sulfonylurea stimulation of glucose transport in rat skeletal muscle.

  2004cites this paper
• The morphological and biochemical effects of glibornuride on rat liver in experimental diabetes

  2004cites this paper
• Sulfonylureas: Basic Aspects and Clinical Uses

  2004cites this paper
• Determination of glimepiride in human plasma using semi-microbore high performance liquid chromatography with column-switching.

  2004cites this paper
• The effect of hyperglycaemia on glucose disposal and insulin signal transduction in skeletal muscle.

  2003cites this paper
• Treatment with intravenous insulin followed by continuous subcutaneous insulin infusion improves glycaemic control in severely resistant Type 2 diabetic patients

  2003cites this paper
• Enhancement of Glucose Uptake in 3T3‐L1 Adipocytes by Toona sinensis Leaf Extract

  2003cites this paper
• Hepatic glucose production: therapeutic target in type 2 diabetes?

  2002cites this paper
• Gliclazide increases insulin receptor tyrosine phosphorylation but not p38 phosphorylation in insulin-resistant skeletal muscle cells.

  2002cites this paper
• Acute effect of glimepiride on insulin-stimulated glucose metabolism in glucose-tolerant insulin-resistant offspring of patients with type 2 diabetes.

  2002cites this paper
• Glimepiride improves both first and second phases of insulin secretion in type 2 diabetes.

  2002cites this paper
• Abnormality in fibre type distribution of soleus and plantaris muscles in non‐obese diabetic Goto‐Kakizaki rats

  2002cites this paper
• The sulfonylurea glimepiride regulates intracellular routing of the insulin-receptor complexes through their interaction with specific protein kinase C isoforms.

  2001cites this paper
• The Importance of β-Cell Failure in the Development and Progression of Type 2 Diabetes

  2001cites this paper
• Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment.

  2001cites this paper
• Comparison of the Effects of Three Sulfonylureas on in vivo Insulin Action

  2001cites this paper
• Concentration of the complement activation product, acylation-stimulating protein, is related to C-reactive protein in patients with type 2 diabetes.

  2001cites this paper
• Decreased responsiveness of gluconeogenesis to the modulation by sulfonylureas in hepatocytes isolated from obese (fa/fa) Zucker rats.

  2001cites this paper
• Oral hypoglycemic agents: insulin secretagogues, alpha-glucosidase inhibitors and insulin sensitizers.

  2001cites this paper
• Pathogenesis of Type 2 Diabetes

  2001cites this paper
• GLUT4 is reduced in slow muscle fibers of type 2 diabetic patients: is insulin resistance in type 2 diabetes a slow, type 1 fiber disease?

  2001cites this paper
• Clinical review 135: The importance of beta-cell failure in the development and progression of type 2 diabetes.

  2001cites this paper
• Insulin action and insulin resistance in human skeletal muscle

  2000cites this paper
• Pathophysiology and pharmacological treatment of insulin resistance.

  2000cites this paper
• Depolarizing stimuli reduce Ca(2+)/calmodulin-dependent protein kinase II activity in islets of Langerhans.

  2000cites this paper
• The in vivo interaction between gliclazide and glibenclamide and insulin on glucose disposal in the rat.

  1999cites this paper
• Muscle fiber type-specific defects in insulin signal transduction to glucose transport in diabetic GK rats.

  1999cites this paper
• Studies of gene expression and activity of hexokinase, phosphofructokinase and glycogen synthase in human skeletal muscle in states of altered insulin-stimulated glucose metabolism.

  1999cites this paper
• Antioxidant status in experimental type 2 diabetes mellitus: effects of glibenclamide and glipizide on various rat tissues.

  1999cites this paper
• Glucosamine infusion in rats rapidly impairs insulin stimulation of phosphoinositide 3-kinase but does not alter activation of Akt/protein kinase B in skeletal muscle.

  1999cites this paper
• GLUT2 and glucokinase expression is coordinately regulated by sulfonylurea.

  1999cites this paper
• The effects of tolbutamide on lipoproteins, lipoprotein lipase and hormone-sensitive lipase.

  1999cites this paper
• EVALU ATION OF INSULIN-SUL FONYLUREA COMBINATION V ERSIJS INSULIN AL ONE IN THE T REATMENT OF NON-INSULIN D EPENDENT DIABETES MELLITU S (NID DM)

  1998cites this paper
• Non-Insulin Dependent Diabetes in Children and Adolescents: The Therapeutic Challenge

  1998cites this paper
• In Most Poorly Controlled Glyburide-Treated Type 2 Diabetic Patients Drug Withdrawal Causes Further Increase in Glycemia not Accompanied by Changes in Insulin Secretion

  1998cites this paper
• A case for glucosamine.

  1998cites this paper
• Increased hepatic glucose production and decreased hepatic glucose uptake at the prediabetic phase in the Otsuka Long-Evans Tokushima fatty rat model.

  1998cites this paper
• Central nervous system nitric oxide synthase activity regulates insulin secretion and insulin action.

  1998cites this paper
• Delayed enhancement of myocardial FDG uptake on glucose loading FDG-PET in NIDDM patient

  1997cites this paper
• Effect of glibenclamide on insulin release at moderate and high blood glucose levels in normal man

  1997cites this paper
• Non-insulin-dependent diabetes mellitus in childhood and adolescence.

  1997cites this paper
• Gliclazide treatment of streptozotocin diabetic rats restores GLUT4 protein content and basal glucose uptake in skeletal muscle.

  1997cites this paper
• Pharmacological regulation of blood glucose levels in non-insulin-dependent diabetes mellitus.

  1997cites this paper
• Glibenclamide: an old drug with a novel mechanism of action?

  1997cites this paper
• Clinical Significance of Insulin Resistance

  1996cites this paper
• Clinical Pharmacology of Sulfonylureas

  1996cites this paper
• Characterization of the Molecular Mode of Action of the Sulfonylurea, Glimepiride, at β-Cells

  1996cites this paper
• Effects of experimental diabetes and insulin on smooth muscle functions.

  1996cites this paper
• Insulin resistance in non-insulin-dependent diabetes mellitus

  1996cites this paper
• Triglyceride‐rich lipoproteins in non‐insulin‐dependent diabetes mellitus: post‐prandial metabolism and relation to premature atherosclerosis

  1996cites this paper
• Oral Antidiabetic Drug Use in the Elderly

  1996cites this paper
• Pharmacokinetics and Pharmacodynamics of Glyburide in Young and Elderly Patients with Non-Insulin-Dependent Diabetes Mellitus

  1996cites this paper
• Sulphonylurea stimulates glucose uptake in rats through an ATP-sensitive K+ channel dependent mechanism

  1996cites this paper